Clifton F. Mountain

Clifton F. Mountain's AcademicInfluence.com Rankings

Clifton F. Mountain

Philosophy

#6360

World Rank

#9385

Historical Rank

Logic

#3536

World Rank

#4715

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Clifton F. Mountain's Degrees

Doctorate Medicine University of Medicine, Taunggyi

Why Is Clifton F. Mountain Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Clifton F. Mountain's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Revisions in the International System for Staging Lung Cancer. (1997) (4680)
Regional lymph node classification for lung cancer staging. (1997) (1399)
The new International Staging System for Lung Cancer. (1986) (1109)
A new international staging system for lung cancer. (1987) (748)
Modern thirty-day operative mortality for surgical resections in lung cancer. (1983) (618)
Survival in early-stage non-small cell lung cancer. (1995) (375)
The international system for staging lung cancer. (2000) (316)
A system for the clinical staging of lung cancer. (1974) (308)
Prognostic factors in patients with resected stage I non‐small cell lung cancer. A report from the Lung Cancer Study Group (1984) (265)
Surgery for pulmonary metastasis: a 20-year experience. (1984) (252)
Five‐year survival after pulmonary metastasectomy for adult soft tissue sarcoma (1992) (237)
Expression of blood-group antigen A--a favorable prognostic factor in non-small-cell lung cancer. (1991) (221)
Predicting loss of pulmonary function after pulmonary resection for bronchogenic carcinoma. (1980) (208)
Lung cancer classification: The relationship of disease extent and cell type to survival in a clinical trials population (1987) (177)
Determinants of perioperative morbidity and mortality after pneumonectomy. (1989) (147)
Extragonadal germ cell tumors. (1973) (141)
Prognostic implications of the International Staging System for Lung Cancer. (1988) (140)
Assessment of the role of surgery for control of lung cancer. (1977) (129)
Radiation‐induced sarcomas of the chest wall (1986) (118)
The natural history of resectable metastatic melanoma (Stage IVA Melanoma) (1982) (111)
Superior sulcus tumors: treatment selection and results for 85 patients without metastasis (Mo) at presentation. (1990) (96)
Expanded possibilities for surgical treatment of lung cancer. Survival in stage IIIa disease. (1990) (96)
The biological operability of stage III non-small cell lung cancer. (1985) (96)
Surgical adjuvant intrapleural BCG treatment for stage I non-small cell lung cancer. Preliminary report of the National Cancer Institute Lung Cancer Study Group. (1981) (95)
Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction. (1990) (92)
Staging classification of lung cancer. A critical evaluation. (2002) (91)
New prognostic factors in lung cancer. Biologic prophets of cancer cell aggression. (1995) (90)
Patterns of mediastinal metastases in bronchogenic carcinoma. (1986) (87)
Current techniques for chest wall reconstruction: expanded possibilities for treatment. (1988) (79)
Surgery for stage IIIa‐N2 non‐small cell lung cancer (1994) (77)
Immune function during intravenous administration of a soybean oil emulsion. (1985) (75)
Parenteral Nutrition in Esophageal Cancer Patients (1982) (70)
Open lung biopsy in immunocompromised patients. (1984) (65)
Value of the New TNM Staging System for Lung Cancer (1989) (65)
Treatment of primary neoplasms of the trachea the role of radiation therapy (1993) (62)
Should subcarinal lymph nodes be routinely examined in patients with non-small cell lung cancer? (1988) (61)
Prolonged chemotherapy for localised squamous carcinoma of the oesophagus. (1992) (60)
Regional and overall pulmonary function changes in lung cancer. Correlations with tumor stage, extent of pulmonary resection, and patient survival. (1983) (56)
The role of preoperative mesenteric arteriography in colon interposition. (1977) (53)
A surgical approach to the treatment of pericardial effusion in cancer patients (1985) (51)
Lung cancer staging classification. (1993) (49)
Efficacy of pulmonary metastasectomy for recurrent soft tissue sarcoma (1991) (46)
CT depiction of regional nodal stations for lung cancer staging. (2000) (43)
A perspective on chest wall resection in patients with breast cancer. (1984) (41)
Role of intravenous hyperalimentation as an adjunct to intensive chemotherapy for small cell bronchogenic carcinoma. (1981) (38)
Should subcarinal lymph nodes be routinely examined in patients with non-small cell lung cancer? The Lung Cancer Study Group. (1988) (36)
Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer. (1998) (35)
Regional pulmonary function before and after pneumonectomy using 133xenon. (1975) (29)
Tumour staging and classification in lung cancer. Summary of the international symposium (2000) (28)
Tumor stage in non-small cell carcinoma of the lung. (1991) (27)
Critical evaluation of the gallium-67 scan for surgical patients with lung cancer. (1985) (26)
STAGING CLASSIFICATION OF LUNG CANCER (2002) (25)
Regional extension of lung cancer. (1980) (25)
Clinical biology of small cell carcinoma: relationship to surgical therapy. (1978) (24)
Staging of Lung Cancer (1981) (23)
Diagnosis for interstitial lung disease in patients with acquired immunodeficiency syndrome (AIDS): a prospective comparison of bronchial washing, alveolar lavage, transbronchial lung biopsy, and open-lung biopsy. (1986) (23)
Staging of lung cancer: The new international system (1987) (23)
Value of the new TNM staging system for lung cancer. (1989) (20)
Comparison of surgery and radiation therapy for non-small cell carcinoma of the lung with mediastinal metastasis. (1991) (19)
Intensive induction chemotherapy of extensive small cell bronchogenic carcinoma in protected environment--prophylactic antibiotic units. A preliminary report. (1980) (19)
Modeling the anticancer action of some retinoid compounds by making use of the OASIS method. (1993) (19)
The postlobectomy chest: anatomic considerations. (1987) (18)
Surgical treatment of lung cancer (1991) (18)
A new international staging system for lung cancer. 1986. (2009) (17)
The basis for surgical resection of pulmonary metastases. (1976) (15)
Surgical management of pulmonary metastases. (1970) (14)
Operation for small-cell carcinoma revisited. (1987) (14)
Chemotherapy of extensive large cell and adenocarcinoma of the lung. A randomized trial in 210 patients (1980) (12)
The role of adjuvant surgery in the combined modality therapy of small-cell bronchogenic carcinoma after a chemotherapy-induced partial remission. (1990) (12)
Tumor staging and classification in lung cancer. Summary of the international symposium. Madrid, Spain, 3-4 December 1999. (2000) (12)
Keynote address on surgery in the therapy for lung cancer: surgical prospects and priorities for clinical research. (1973) (9)
The staging of lung cancer. (1978) (9)
The evolution of the surgical treatment of lung cancer. (2000) (8)
Comparison of chemotherapy alone versus chemotherapy and radiation therapy of extensive small cell carcinoma of the lung (1983) (8)
Surgical treatment of lung cancer. Past and present. (2003) (8)
Combined therapy for carcinoma of the esophagus: panacea or puzzle? (1988) (7)
A NEW INTERNATIONAL STAGING OF LUNG CÁNCER (1987) (7)
Comment: Pulmonary metastatic disease—progress in a neglected area (1976) (7)
The antihistaminic drugs in the treatment of the common cold; a study conducted at Boston University. (1951) (7)
Surgical therapy in lung cancer: biologic, physiologic, and technical determinants. (1974) (7)
Modeling the anticarcinogenic action of retinoids by making use of the OASIS method. 3. Inhibition of the induction of ornithine decarboxylase by arotinoids. (1994) (5)
Early side effects of intrathoracic BCG therapy in patients with stage I squamous cell carcinoma, adenocarcinoma, or large cell lung cancer (1981) (4)
The Role of Adjuvant Therapy in the Surgical Treatment of Lung Cancer (1982) (3)
Prolonged stabilization of progressive squamous cell cancer of the cervix with interferon-alpha and 13-cis-retinoic acid: report of two cases and review of the literature. (1996) (3)
Increasing importance of adjuvant surgery in inoperable lung cancer. (1984) (3)
A Surgeon’s Insight into Tumor Behavior (1977) (3)
The conformational flexibility of aromatic retinoids. (1994) (2)
Therapy of stage I and stage II non-small cell lung cancer. (1983) (2)
Communications to the EditorReflections on the Revisions in the International System for Staging Lung Cancer (1998) (1)
The Role of Imaging in Lung Cancer (2008) (1)
Evaluation of kanamycin in the local treatment of pyodermias. (1958) (1)
Characterization of normal and diseased tissue by argon-ion laser-induced fluorescence (1987) (1)
Comparisons of surgery and radiation therapy for non-small cell carcinoma of lung (NSCCL) with mediastinal metastasis (N2MO) (1990) (1)
O-070 The Odyssey of lung cancer staging: The new frontier (2005) (1)
The role of mediastinoscopy in the management of lung cancer. (1970) (1)
The presence of steroid hormone receptors in human lung cancer (1985) (1)
Methotrexate (MTX) and asparaginase (ASP) in drug refractory human tumors (1976) (0)
special report Revisions intheInternational System forStaging Lung Cancer (2017) (0)
Correlation of Emetic and Hypotensive Doses of Veratrum in Pigeon, Dog and Human.∗ (1955) (0)
Cancer chemotherapy. II. (1962) (0)
Mediastinal Synovial Sarcoma (1993) (0)
Lung cancer. Lung Oncology Workgroup, Legislative Task Force on Cancer in Texas. (1987) (0)
Panel report. The surgeon's viewpoint on collaborative research on lung cancer. (1973) (0)
Statistics of Esophageal Cancer Progression in Man (1989) (0)
Statistics of Lung Cancer Progression in Man (1989) (0)
624 Tumor biomarkers in lung cancer: An analysis of patients with pathologically staged N1 nonsmall cell lung cancer (NSCLC) (1997) (0)
Communications to the EditorErratum (1990) (0)
Regional Lymph NodeClassification for Lung CancerStaging (2015) (0)
Sureew for Pulmonarv Me&s&sis: A 20-Year kxperience (1984) (0)
Cytodiagnosis of lung cancer: a report of four-year laboratory, clinical study with a review of the literature on lung cancer and pulmonary cytology. (1963) (0)
Expanded possibilities for surgical treatment of lung cancer. Survival in stage IIIa disease. 1990. (2009) (0)
Corrigendum to “Tumor biomarkers in lung cancer: An analysis of patients with pathologically staged N1 non small cell lung cancer (NSCLC)” [Lung Cancer 18 (S1) (1997) 160] (2013) (0)
21 – Staging of Lung Cancer (2010) (0)
Surgical critical care: who is responsible? (1992) (0)
[Combined (surgical and drug) therapy of lung cancer]. (1983) (0)
O-209 Lung cancer staging: Additional specificity for researchers by decimal point notation (2003) (0)
Acta Cytologica 40 Years Ago Volume VII, Number 1, 1963 (2003) (0)
P-488 Biologic markers of prognosis in lung cancer: Are we there yet? (2003) (0)
THE STAGING OF LUNG CANCER : PAST, PRESENT and FUTURE (2004) (0)
Chemotherapy as an adjunct to surgery in the treatment of pulmonary malignant disease. (1971) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Clifton F. Mountain?

Clifton F. Mountain is affiliated with the following schools:

University of California, San Diego